scispace - formally typeset
V

Valeriu Crudu

Researcher at Moldova State University

Publications -  60
Citations -  2719

Valeriu Crudu is an academic researcher from Moldova State University. The author has contributed to research in topics: Tuberculosis & Mycobacterium tuberculosis. The author has an hindex of 21, co-authored 50 publications receiving 2062 citations.

Papers
More filters
Journal ArticleDOI

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

TL;DR: It is shown that this lineage of mycobacterium tuberculosis strains of the Beijing lineage initially originated in the Far East, from where it radiated worldwide in several waves and detected successive increases in population size over the last 200 years.
Journal ArticleDOI

Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages.

David Stucki, +94 more
- 01 Dec 2016 - 
TL;DR: It is shown that lineage 4 comprises globally distributed and geographically restricted sublineages, suggesting a distinction between generalists and specialists, and further support a European origin for the most common generalist sublineage.
Journal ArticleDOI

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

Michael J. A. Reid, +83 more
- 30 Mar 2019 - 
TL;DR: The Commission recommends five priority investments to achieve a tuberculosis-free world within a generation, which answer the question of how countries with high-burden tuberculosis and their development partners should target their future investments.
Journal ArticleDOI

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance

TL;DR: Molecular diagnostics that include markers for rifampicin resistance alone will be insufficient to identify pre-MDR strains, and incorporation of knowledge of polymorphisms that occur before the emergence of multidrug resistance, particularly katG p.Ser315Thr, into molecular diagnostics should enable targeted treatment of patients with pre-mDR-TB to prevent further development of MDR- TB.